CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 110 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02491567
NCT02491567N/ACompleted

Study of DNA Methylation in Children and Adolescents With Autoimmune Thyroid Diseases

Aristotle University Of Thessaloniki·observational·Posted Jul 8, 2015·Updated Sep 26, 2019

In Brief

An observational study for Hashimoto Thyroiditis and Graves Disease. Completed, enrolled 110 participants across 1 site.

Detailed Summary

Hashimoto Thyroiditis (HT) and Graves Disease (GD) are known to be caused by abnormal immune response against self cells and tissues. Epigenetics is a novel field of biology studying the mechanisms by which the environment interacts with the genotype to produce a variety of phenotypes through modifications to chromatin that do not directly alter the DNA sequence. A very limited number of epigenetic studies have been published in patients with HT and GD so far. Therefore, the purpose of this study is to analyze DNA methylation status in White Blood Cells (WBCs) within the promoter regions of genomic sites that have been previously identified as susceptibility loci or sites for autoimmune thyroid disease, such as the CD40L, FOXP3, CTLA4, PTPN22, IL2RA, FCRL3 and HLADRB1 genes.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGreece
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 8, 2015
Enrollment StartSep 1, 2014
Primary CompletionSep 1, 2016
Study CompletionApr 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 11.0 years ago